(Q80950456)
Statements
Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sézary syndrome (English)
Simon D J Gibbs
Kirsten E Herbert
Christopher McCormack
John F Seymour
H Miles Prince
1 December 2004